Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG - HSA Drug Approval Details

Approvals/HSA/DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG

Approved

THERAPEUTIC

DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG

Sandoz Private Limited🇸🇬 Health Sciences Authority

Approval Date: Mar 7, 2025
Approval ID: d23802991f2ca3bf
Company: Sandoz Private Limited
Type: Therapeutic

Approval Details

Approval Id: d23802991f2ca3bf
Drug Name: DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG
Product Name: DAPAGLIFLOZIN SANDOZ FILM COATED TABLET 10MG
Approval Number: SIN17199P
Approval Date: 2025-03-07
Registrant: SANDOZ SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: A10BK01
Pharma Manufacturer Name: SANDOZ SINGAPORE PTE. LTD.
Company Detail Path: /organization/e4e3c23e844d6425/sandoz-singapore-pte-ltd

Active Ingredients

Dapagliflozin

10.000mg

Dapagliflozin

10.000mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 7, 2025

Approval ID

d23802991f2ca3bf

Type

Therapeutic

Back to HSA Approvals